Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
15 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250715146338/en/Kairos-Pharma-Announces-Positive-Safety-Results-from-Phase-2-Trial-of-ENV-105-in-Advanced-Prostate-Cancer
03 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250603180931/en/Kairos-Pharma-Ltd.-Announces-New-Data-on-Small-Molecule-GITR-Ligand-Agonist-KROS-101-as-Promising-Cancer-Immunotherapy-at-the-American-Society-of-Clinical-Oncology-ASCO-2025-Annual-Meeting
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428474374/en/Kairos-Pharma-Ltd.-Announces-Data-to-be-Presented-at-the-American-Society-of-Clinical-Oncology-ASCO-2025-Annual-Meeting
24 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250424430440/en/Kairos-Pharma-Ltd.-Provides-Letter-to-Stockholders
17 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250417176796/en/Kairos-Pharma-Ltd.-Announces-Department-of-Defense-Grant-to-Support-Its-Study-of-Lead-Compound-ENV105-to-Prevent-Drug-Resistance-in-Lung-Cancer
31 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250331802726/en/Kairos-Pharma-Ltd.-Announces-Completed-Enrollment-of-the-Safety-Arm-of-Its-Phase-2-Clinical-Trial-of-ENV105-in-Metastatic-Castration-Resistant-Prostate-Cancer
ABOUT THIS PAGE